Associations between interleukin and interleukin receptor gene polymorphisms and risk of gout

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Liu, Shiguo ^a   Zhou, Zheng ^a   Wang, Can ^a   Guo, Mingzhen ^a   Chu, Nan ^b   Li, Changgui ^a  

^a QINGDAO UNIVERSITY   (China)

^b Qingdao HaiCi Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR;

ADULT; ALLELE; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; GOUT; HUMAN; MALE; MIDDLE AGED; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GOUT; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN; RISK;

EID: 84942414578     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13887     Document Type: Article

References (35)

1. Smith, E. et al. The global burden of gout: estimates from the Global Burden of Disease 2010 study. Annals of the rheumatic diseases 73, 1470-1476, doi: 10.1136/annrheumdis-2013-204647 (2014).
2. Roddy, E., Zhang, W. & Doherty, M. The changing epidemiology of gout. Nature clinical practice. Rheumatology 3, 443-449, doi: 10.1038/ncprheum0556 (2007).
3. Kuo, C. F., Grainge, M. J., Mallen, C., Zhang, W. & Doherty, M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Annals of the rheumatic diseases. doi: 10.1136/annrheumdis-2013-204463 (2014).
4. Kuo, C. F. et al. Epidemiology and management of gout in Taiwan: a nationwide population study. Arthritis research & therapy 17, 13, doi: 10.1186/s13075-015-0522-8 (2015).
5. Takada, T. et al. ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion. Nucleosides, nucleotides & nucleic acids 33, 275-281, doi: 10.1080/15257770.2013.854902 (2014).
6. George, R. L. & Keenan, R. T. Genetics of hyperuricemia and gout: implications for the present and future. Current rheumatology reports 15, 309, doi: 10.1007/s11926-012-0309-8 (2013).
7. Kolz, M. et al. Meta-analysis of 28, 141 individuals identifes common variants within fve new loci that infuence uric acid concentrations. PLoS genetics 5, e1000504, doi: 10.1371/journal.pgen.1000504 (2009).
8. Miao, Z. M. et al. Epidemiological survey of hyperuricemia and gout in coastal areas of Shandong province. Chin J Endocrinol Metab 22, 421-425, doi: 10.3760/j.issn:1000-6699.2006.05.005 (2006).
9. Malawista, S. E., de Boisfeury, A. C. & Naccache, P. H. Infammatory gout: observations over a half-century. FASEB journal: ofcial publication of the Federation of American Societies for Experimental Biology 25, 4073-4078, doi: 10.1096/f.11-1201ufm (2011).
10. Popa-Nita, O. & Naccache, P. H. Crystal-induced neutrophil activation. Immunology and cell biology 88, 32-40, doi: 10.1038/icb.2009.98 (2010).
11. Xu, D. et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proceedings of the National Academy of Sciences of the United States of America 105, 10913-10918, doi: 10.1073/pnas.0801898105 (2008).
12. Palmer, G. et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis and rheumatism 60, 738-749, doi: 10.1002/art.24305 (2009).
13. Aggarwal, S. & Gurney, A. L. IL-17: prototype member of an emerging cytokine family. Journal of leukocyte biology 71, 1-8 (2002).
14. Watford, W. T. et al. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunological reviews 202, 139-156, doi: 10.1111/j.0105-2896.2004.00211.x (2004).
15. Mathur, A. N. et al. Stat3 and Stat4 direct development of IL-17-secreting T cells. Journal of immunology 178, 4901-4907 (2007).
16. Ghaemi-Oskouie, F. & Shi, Y. The role of uric acid as an endogenous danger signal in immunity and infammation. Current rheumatology reports 13, 160-166, doi: 10.1007/s11926-011-0162-1 (2011).
17. Kingsbury, S. R., Conaghan, P. G. & McDermott, M. F. The role of the NLRP3 infammasome in gout. Journal of infammation research 4, 39-49, doi: 10.2147/JIR.S11330 (2011).
18. Liu, S., Yin, C., Chu, N., Han, L. & Li, C. IL-8-251T/A and IL-12B 1188A/C polymorphisms are associated with gout in a Chinese male population. Scandinavian journal of rheumatology 42, 150-158, doi: 10.3109/03009742.2012.726372 (2013).
19. Liu, S. et al. The rs7517847 polymorphism in the IL-23R gene is associated with gout in a Chinese Han male population. Modern rheumatology/the Japan Rheumatism Association, 1-4, doi: 10.3109/14397595.2014.964823 (2015).
20. Tsai, P. C., Chen, C. J., Lai, H. M. & Chang, S. J. Analysis of polymorphisms in the promoter region and protein levels of interleukin-6 gene among gout patients. Clinical and experimental rheumatology 26, 841-847 (2008).
21. Schmitz, J. et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490, doi: 10.1016/j.immuni.2005.09.015 (2005).
22. Ekinci, N. S., Alpsoy, E., Karakas, A. A., Yilmaz, S. B. & Yegin, O. IL-17A has an important role in the acute attacks of Behcet's disease. The Journal of investigative dermatology 130, 2136-2138, doi: 10.1038/jid.2010.114 (2010).
23. Huber, A. K., Jacobson, E. M., Jazdzewski, K., Concepcion, E. S. & Tomer, Y. Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. The Journal of clinical endocrinology and metabolism 93, 1077-1081, doi: 10.1210/jc.2007-2190 (2008).
24. Sung, I. H. et al. IL-23R polymorphisms in patients with ankylosing spondylitis in Korea. The Journal of rheumatology 36, 1003-1005, doi: 10.3899/jrheum.081121 (2009).
25. Mizuki, N. et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nature genetics 42, 703-706, doi: 10.1038/ng.624 (2010).
26. Remmers, E. F. et al. Genome-wide association study identifes variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nature genetics 42, 698-702, doi: 10.1038/ng.625 (2010).
27. Happel, K. I. et al. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. Journal of immunology 170, 4432-4436 (2003).
28. Miossec, P. Interleukin-17 in fashion, at last: ten years afer its description, its cellular source has been identifed. Arthritis and rheumatism 56, 2111-2115, doi: 10.1002/art.22733 (2007).
29. Carriere, V. et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proceedings of the National Academy of Sciences of the United States of America 104, 282-287, doi: 10.1073/pnas.0606854104 (2007).
30. Oboki, K., Ohno, T., Kajiwara, N., Saito, H. & Nakae, S. IL-33 and IL-33 receptors in host defense and diseases. Allergology international: ofcial journal of the Japanese Society of Allergology 59, 143-160, doi: 10.2332/allergolint.10-RAI-0186 (2010).
31. Hayakawa, H., Hayakawa, M., Kume, A. & Tominaga, S. Soluble ST2 blocks interleukin-33 signaling in allergic airway infammation. The Journal of biological chemistry 282, 26369-26380, doi: 10.1074/jbc.M704916200 (2007).
32. Iikura, M. et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Laboratory investigation; a journal of technical methods and pathology 87, 971-978, doi: 10.1038/labinvest.3700663 (2007).
33. Fodil, M. et al. Association of PTPN22 (rs2476601) and STAT4 (rs7574865) polymorphisms with Rheumatoid Arthritis in the Western Algerian population. Acta reumatologica portuguesa (2014).
34. Jiang, X., Zhou, Z., Zhang, Y., Yang, H. & Ren, K. An updated meta-analysis of the signal transducer and activator of transcription 4 (STAT4) rs7574865 G/T polymorphism and rheumatoid arthritis risk in an Asian population. Scandinavian journal of rheumatology 43, 477-480, doi: 10.3109/03009742.2014.918174 (2014).
35. Wallace, S. L. et al. Preliminary criteria for the classifcation of the acute arthritis of primary gout. Arthritis and rheumatism 20, 895-900 (1977).